231 related articles for article (PubMed ID: 19427822)
1. [Safety and efficacy of oral tacrolimus in the treatment of paediatric inflammatory bowel disease].
Navas López VM; Blasco Alonso J; Sierra Salinas C; Barco Gálvez A; Vicioso Recio MI
An Pediatr (Barc); 2009 Jun; 70(6):519-25. PubMed ID: 19427822
[TBL] [Abstract][Full Text] [Related]
2. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.
Ziring DA; Wu SS; Mow WS; Martín MG; Mehra M; Ament ME
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):306-11. PubMed ID: 17873742
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
[TBL] [Abstract][Full Text] [Related]
4. Oral tacrolimus for pediatric steroid-resistant ulcerative colitis.
Navas-López VM; Blasco Alonso J; Serrano Nieto MJ; Girón Fernández-Crehuet F; Argos Rodriguez MD; Sierra Salinas C
J Crohns Colitis; 2014 Jan; 8(1):64-9. PubMed ID: 23582736
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.
Yamamoto S; Nakase H; Mikami S; Inoue S; Yoshino T; Takeda Y; Kasahara K; Ueno S; Uza N; Kitamura H; Tamaki H; Matsuura M; Inui K; Chiba T
Aliment Pharmacol Ther; 2008 Sep; 28(5):589-97. PubMed ID: 18549460
[TBL] [Abstract][Full Text] [Related]
6. Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice.
Tursi A; Elisei W; Brandimarte G; Giorgetti G; Penna A; Castrignano V
Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):47-55. PubMed ID: 20184089
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
8. Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases.
Newby EA; Croft NM; Green M; Hassan K; Heuschkel RB; Jenkins H; Casson DH
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):539-45. PubMed ID: 18493209
[TBL] [Abstract][Full Text] [Related]
9. Oral tacrolimus treatment of severe colitis in children.
Bousvaros A; Kirschner BS; Werlin SL; Parker-Hartigan L; Daum F; Freeman KB; Balint JP; Day AS; Griffiths AM; Zurakowski D; Ferry GD; Leichtner AM
J Pediatr; 2000 Dec; 137(6):794-9. PubMed ID: 11113835
[TBL] [Abstract][Full Text] [Related]
10. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
Dejaco C; Haas T; Kirchgatterer A; Miehsler W; Wenzl H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W; Tilg H
Z Gastroenterol; 2006 Jun; 44(6):525-38; discussion 539. PubMed ID: 16773519
[TBL] [Abstract][Full Text] [Related]
11. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.
Ng SC; Arebi N; Kamm MA
Inflamm Bowel Dis; 2007 Feb; 13(2):129-34. PubMed ID: 17206694
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
13. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
15. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.
Ogata H; Matsui T; Nakamura M; Iida M; Takazoe M; Suzuki Y; Hibi T
Gut; 2006 Sep; 55(9):1255-62. PubMed ID: 16484504
[TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.
Schmidt KJ; Herrlinger KR; Emmrich J; Barthel D; Koc H; Lehnert H; Stange EF; Fellermann K; Büning J
Aliment Pharmacol Ther; 2013 Jan; 37(1):129-36. PubMed ID: 23121200
[TBL] [Abstract][Full Text] [Related]
17. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A;
Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
[TBL] [Abstract][Full Text] [Related]
18. Treatment of erosive oral lichen planus with topical tacrolimus.
Thomson MA; Hamburger J; Stewart DG; Lewis HM
J Dermatolog Treat; 2004 Sep; 15(5):308-14. PubMed ID: 15370399
[TBL] [Abstract][Full Text] [Related]
19. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres.
Landy J; Wahed M; Peake ST; Hussein M; Ng SC; Lindsay JO; Hart AL
J Crohns Colitis; 2013 Dec; 7(11):e516-21. PubMed ID: 23623737
[TBL] [Abstract][Full Text] [Related]
20. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.
Sternthal MB; Murphy SJ; George J; Kornbluth A; Lichtiger S; Present DH
Am J Gastroenterol; 2008 Apr; 103(4):937-43. PubMed ID: 18177449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
